Chelsea Scores FDA Approval for Blood Pressure Drug Northera

Drug Industry Daily
A A
Chelsea Therapeutics’ orphan blood-pressure drug Northera won FDA approval Tuesday, following a rocky review path that included two advisory panel nods and a complete response letter.

To View This Article:

Login

Subscribe To Drug Industry Daily